# Efficacy and Safety of Interferon-Gamma Monoclonal Antibody Combined With Dexamethasone in the Treatment of Refractory Adult Secondary Hemophagocytic Lymphohistiocytosis

> **NCT07531069** · — · COMPLETED · sponsor: **Fudan University** · enrollment: 22 (actual)

## Conditions studied

- Adult Refractory Secondary Hemophagocytic Lymphohistiocytosis
- Secondary Hemophagocytic Lymphohistiocytosis
- HLH

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07531069
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-05-21
- **Primary completion:** 2025-08-31
- **Final completion:** 2025-08-31
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2026-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07531069

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07531069, "Efficacy and Safety of Interferon-Gamma Monoclonal Antibody Combined With Dexamethasone in the Treatment of Refractory Adult Secondary Hemophagocytic Lymphohistiocytosis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07531069. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*